There have been no material changes to our market risk exposures during the three and six months ended July 31, 2026, compared to our disclosures in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended January 31, 2026. For a discussion of the derivative contracts initiated during the three months ended July 31, 2026 to manage these risks, see below. Foreign Currency Risk Historically, nearly all of our sales contracts have been denominated in U.S. dollars. A portion of our operating expenses are incurred outside the United States, denominated in foreign currencies, and subject to fluctuations due to changes in foreign currency exchange rates. The functional currencies of our foreign subsidiaries are generally the country’s local currency. Foreign currency transaction gains and losses are recorded to other income (expense), net. To manage the risk of cash flow variability of these operating expenses, we enter into derivative contracts to hedge a portion of our forecasted foreign currency denominated cash flow. These foreign currency forward contracts have a maximum maturity of 3 months as of July 31, 2026 and are designated as cash flow hedges to protect our earnings subjected to foreign currency risk. A hypothetical 10% appreciation in the relative value of the U.S. dollar against such foreign currencies as of July 31, 2026 would not have a material impact to our results of operations or cash flows. For additional information regarding our derivative financial instruments and hedging activities, see Note 4, “Derivative Contracts,” to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.